Latest news and articles about biotech.
10 articles
Relation Therapeutics is tackling the data scarcity issue in AI-driven biology by manufacturing the datasets needed to train AI models of the cell. GSK has committed up to $110 million to support this effort.
Novo Nordisk has handed over its discontinued Parkinson’s therapy STEM-PD to AI biotech startup Cellular Intelligence, in a deal that includes equity stakes and future milestone payments.
Learn how to work with laminin protein data using Python and bioinformatics tools to understand the structural basis of cell therapies.
Learn how to analyze RNA modifications using Python, simulating the technology behind STORM Therapeutics' RNA-modifying enzyme inhibitors.
HexemBio raises $10.4M to develop a novel stem cell rejuvenation therapy targeting blood cancers through a Nature-published approach that recreates embryonic conditions.
Learn how MaxToki, a new AI system, predicts how your cells age by analyzing gene activity over time. Discover why this breakthrough could revolutionize medicine and aging research.
This article explains how artificial intelligence is revolutionizing biotechnology through machine learning applications in drug discovery and protein engineering, using the recent Anthropic acquisition of Coefficient Bio as a case study.
Dutch biotech Laigo Bio has raised €17 million in seed funding to advance its innovative SureTACs platform, which targets previously 'undruggable' membrane proteins through protein degradation.
German biotech Kupando has raised €10M to advance its innate immunity drug KUP101 into human clinical trials, targeting solid tumors and drug-resistant infections.
Learn how gene editing technology, especially CRISPR, is being used to save bananas from a deadly disease and protect global food security.
